Benzinga | Jul 1, 2021 05:00AM EDT

Raymond James Initiates Coverage On Vertex Pharmaceuticals with Market Perform Rating

Raymond James analyst Danielle Brill initiates coverage on Vertex Pharmaceuticals (NASDAQ:VRTX) with a Market Perform rating.